Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 8.

Grantham, Jared J; Chapman, Arlene B; Blais, Jaime; Czerwiec, Frank S; Devuyst, Olivier; Gansevoort, Ron T; Higashihara, Eiji; Krasa, Holly; Zhou, Wen; Ouyang, John; Perrone, Ronald D; Torres, Vicente E (2017). Tolvaptan suppresses monocyte chemotactic protein-1 excretion in autosomal-dominant polycystic kidney disease. Nephrology, Dialysis, Transplantation, 32(6):969-975.

Gansevoort, Ron T; Meijer, Esther; Chapman, Arlene B; Czerwiec, Frank S; Devuyst, Olivier; Grantham, Jared J; Higashihara, Eiji; Krasa, Holly B; Ouyang, John; Perrone, Ronald D; Torres, Vicente E (2016). Albuminuria and tolvaptan in autosomal-dominant polycystic kidney disease: results of the TEMPO 3:4 Trial. Nephrology, Dialysis, Transplantation, 31(11):1887-1894.

Gansevoort, Ron T; Arici, Mustafa; Benzing, Thomas; Birn, Henrik; Capasso, Giovambattista; Covic, Adrian; Devuyst, Olivier; Drechsler, Christiane; Eckardt, Kai-Uwe; Emma, Francesco; Knebelmann, Bertrand; Le Meur, Yannick; Massy, Ziad A; Ong, Albert C.M; Ortiz, Alberto; Schaefer, Franz; Torra, Roser; Vanholder, Raymond; Więcek, Andrzej; Zoccali, Carmine; Van Biesen, Wim (2016). Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best Practice. Nephrology, Dialysis, Transplantation, 31(3):337-348.

Chapman, Arlene B; Devuyst, Olivier; Eckardt, Kai-Uwe; Gansevoort, Ron T; Harris, Tess; Horie, Shigeo; Kasiske, Bertram L; Odland, Dwight; Pei, York; Perrone, Ronald D; Pirson, Yves; Schrier, Robert W; Torra, Roser; Torres, Vicente E; Watnick, Terry; Wheeler, David C (2015). Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a kidney disease: Improving global outcomes (KDIGO) controversies conference. Kidney International, 88(1):17-27.

Petzold, Katja; Gansevoort, Ron T; Ong, Albert C M; Devuyst, Olivier; Rotar, Laura; Eckardt, Kai-Uwe; Köttgen, Anna; Pirson, Yves; Remuzzi, Giuseppe; Sandford, Richard; Tesar, Vladimir; Ecder, Tevfik; Chaveau, Dominique; Torra, Roser; Budde, Klemens; Le Meur, Yannick; Wüthrich, Rudolf P; Serra, Andreas L (2014). Building a network of ADPKD reference centres across Europe: the EuroCYST initiative. Nephrology, Dialysis, Transplantation, 29 Suppl:iv26-iv32.

Spithoven, Edwin M; Kramer, Anneke; Meijer, Esther; Orskov, Bjarne; Wanner, Christoph; Abad, Jose M; Aresté, Nuria; de la Torre, Ramón Alonso; Caskey, Fergus; Couchoud, Cécile; Finne, Patrik; Heaf, James; Hoitsma, Andries; de Meester, Johan; Pascual, Julio; Postorino, Maurizio; Ravani, Pietro; Zurriaga, Oscar; Jager, Kitty J; Gansevoort, Ron T (2014). Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe: prevalence and survival - an analysis of data from the ERA-EDTA Registry. Nephrology, Dialysis, Transplantation, 29 Suppl:iv15-iv25.

Spithoven, Edwin M; Kramer, Anneke; Meijer, Esther; Orskov, Bjarne; Wanner, Christoph; Caskey, Fergus; Collart, Frederic; Finne, Patrik; Fogarty, Damian G; Groothoff, Jaap W; Hoitsma, Andries; Nogier, Marie-Béatrice; Postorino, Maurizio; Ravani, Pietro; Zurriaga, Oscar; Jager, Kitty J; Gansevoort, Ron T (2014). Analysis of data from the ERA-EDTA Registry indicates that conventional treatments for chronic kidney disease do not reduce the need for renal replacement therapy in autosomal dominant polycystic kidney disease. Kidney International, 86(6):1244-1252.

Torres, Vicente E; Chapman, Arlene B; Devuyst, Olivier; Gansevoort, Ron T; Grantham, Jared J; Higashihara, Eiji; Perrone, Ronald D; Krasa, Holly B; Ouyang, John; Czerwiec, Frank S (2012). Tolvaptan in patients with autosomal dominant polycystic kidney disease. The New England Journal of Medicine, 367(25):2407-2418.

This list was generated on Sat Nov 25 01:36:08 2017 CET.